Morus

Crafting through Tradition, Thriving with Nutrition

Morus was founded in 2021, is headquartered in Tokyo, Japan, lists 1–10 employees, and has $5.0M in recorded funding across 1 round.

Headquarters
Tokyo
Employees
1–10
Founded
2021
Business Model
B2B
Website
morus.jp
Total Funding
$5.0M
Last Round
$5.0M Series AJul 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

Morus Inc. is a Tokyo-based biotech startup spun out of Shinshu University that revives Japan's 5,000-year silkworm heritage to produce next-generation functional ingredients for food, cosmetics, feed, and pharmaceutical applications. Through joint research with one of the world's leading silkworm scientists, Morus has developed MorSilk® Powder—a 100% silkworm-derived ingredient rich in essential amino acids, 1-deoxynojirimycin (DNJ), and silk proteins with a natural matcha-like flavor. The company also markets its own functional food brand KAIKO®, offers OEM manufacturing, and conducts joint research with global partners to scale mass production of silkworm biomaterials.

Summary

Morus is a Biotech company based in Tokyo, Japan, founded in 2021. It lists 1–10 employees. It has raised $5.0M in total across 1 round, most recently a $5.0M Series A round in Jul 2025. Investors include SPARX Asset Management and Mizuho Capital.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJul 2025
$5.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Morus on Indexed.vc
<a href="https://indexed.vc/companies/morus"><img src="https://indexed.vc/api/badge/company/morus" alt="Morus on Indexed.vc" width="260" height="76" /></a>